CD22-directed antibodies are used to treat conditions like hairy cell leukemia. They work by targeting CD22 proteins found on the surface of B cells, which helps to destroy cancerous cells. One example was an infusion called Lumoxiti (moxetumomab pasudotox), but it has been discontinued by its manufacturer.
MOXETUMOMAB PASUDOTOX treats leukemia. It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells.
Disclaimer: Popularity is based on total prescriptions for the brand and generic versions of each drug, regardless of the condition being treated. Some drugs are prescribed for multiple conditions.
Subscribe and save
Get prescription saving tips and more from GoodRx Health. Enter your email to sign up
